<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Child Adolesc Psychiatry Ment Health</journal-id><journal-title>Child and Adolescent Psychiatry and Mental Health</journal-title><issn pub-type="epub">1753-2000</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1753-2000-2-33</article-id><article-id pub-id-type="pmid">19014633</article-id><article-id pub-id-type="doi">10.1186/1753-2000-2-33</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>M&#x000fc;ller</surname><given-names>Timo Dirk</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I10">10</xref><email>timo.mueller@uni-due.de</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Reichwald</surname><given-names>Kathrin</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>kathrinr@fli-leibniz.de</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Br&#x000f6;nner</surname><given-names>G&#x000fc;nter</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>broenner@biozentrum.uni-wuerzburg.de</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Kirschner</surname><given-names>Jeanette</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>jkirschn@fli-leibniz.de</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Nguyen</surname><given-names>Thuy Trang</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>nguyent@med.uni-marburg.de</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Scherag</surname><given-names>Andr&#x000e9;</given-names></name><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I5">5</xref><email>Andre.Scherag@uk-essen.de</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Herzog</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>Wolfgang.Herzog@med.uni-heidelberg.de</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Herpertz-Dahlmann</surname><given-names>Beate</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>b.herpertz-dahlmann@kjp.rwth-aachen.de</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Lichtner</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="I8">8</xref><xref ref-type="aff" rid="I9">9</xref><email>lichtner@gsf.de</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Meitinger</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="I8">8</xref><xref ref-type="aff" rid="I9">9</xref><email>meitinger@gsf.de</email></contrib><contrib id="A11" contrib-type="author"><name><surname>Platzer</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>mplatzer@fli-leibniz.de</email></contrib><contrib id="A12" contrib-type="author"><name><surname>Sch&#x000e4;fer</surname><given-names>Helmut</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>hsimbe@staff.uni-marburg.de</email></contrib><contrib id="A13" contrib-type="author"><name><surname>Hebebrand</surname><given-names>Johannes</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>johannes.hebebrand@uni-due.de</email></contrib><contrib id="A14" corresp="yes" contrib-type="author"><name><surname>Hinney</surname><given-names>Anke</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>anke.hinney@uni-due.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Child and Adolescent Psychiatry, University of Duisburg-Essen, Essen, Germany</aff><aff id="I2"><label>2</label>Leibniz Institute for Age Research &#x02013; Fritz Lipmann Institute (FLI), Jena, Germany</aff><aff id="I3"><label>3</label>Biocenter of the University of Wuerzburg, Wuerzburg, Germany</aff><aff id="I4"><label>4</label>Institute of Medical Biometry and Epidemiology, Philipps-University, Marburg, Germany</aff><aff id="I5"><label>5</label>Institute of Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany</aff><aff id="I6"><label>6</label>Klinik f&#x000fc;r Psychosomatische und Allgemeine Klinische Medizin, Universit&#x000e4;tsklinikum Heidelberg, University of Heidelberg, Germany</aff><aff id="I7"><label>7</label>Department of Child and Adolescent Psychiatry and Psychotherapy, University Clinics, Technical University of Aachen, Aachen, Germany</aff><aff id="I8"><label>8</label>Institute of Human Genetics, Technical University Munich, Munich, Germany</aff><aff id="I9"><label>9</label>GSF &#x02013; National Research Center for Environment and Health, M&#x000fc;nchen-Neuherberg, Germany</aff><aff id="I10"><label>10</label>Department of Psychiatry, University of Cincinnati Genome Research Institute, Cincinnati, OH, USA</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>17</day><month>11</month><year>2008</year></pub-date><volume>2</volume><fpage>33</fpage><lpage>33</lpage><ext-link ext-link-type="uri" xlink:href="http://www.capmh.com/content/2/1/33"/><history><date date-type="received"><day>6</day><month>8</month><year>2008</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 M&#x000fc;ller et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>M&#x000fc;ller et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> M&#x000fc;ller Dirk Timo timo.mueller@uni-due.de </dc:author><dc:title> Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>Child and Adolescent Psychiatry and Mental Health 2(1): 33-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1753-2000(2008)2:1&#x0003c;33&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1753-2000</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Several lines of evidence indicate that the central cannabinoid receptor 1 (CNR1) as well as the major endocannabinoid degrading enzymes fatty acid amide hydrolase (FAAH), N-acylethanolamine-hydrolyzing acid amidase (NAAA) and monoglyceride lipase (MGLL) are implicated in mediating the orexigenic effects of cannabinoids. The aim of this study was to analyse whether nucleotide sequence variations in the <italic>CNR1</italic>, <italic>FAAH</italic>, <italic>NAAA </italic>and <italic>MGLL </italic>genes are associated with anorexia nervosa (AN).</p></sec><sec sec-type="methods"><title>Methods</title><p>We analysed the association of a previously described (AAT)n repeat in the 3' flanking region of CNR1 as well as a total of 15 single nucleotide polymorphisms (SNPs) representative of regions with restricted haplotype diversity in <italic>CNR1</italic>, <italic>FAAH</italic>, <italic>NAAA </italic>or <italic>MGLL </italic>in up to 91 German AN trios (patient with AN and both biological parents) using the transmission-disequilibrium-test (TDT). One SNP was additionally analysed in an independent case-control study comprising 113 patients with AN and 178 normal weight controls. Genotyping was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, ARMS-PCR or using 3730xl capillary sequencers.</p></sec><sec><title>Results</title><p>The TDT revealed no evidence for association for any of the SNPs or the (AAT)n repeat with AN (all two-sided uncorrected p-values &#x0003e; 0.05). The lowest p-value of 0.11 was detected for the A-allele of the <italic>CNR1 </italic>SNP rs1049353 for which the transmission rate was 59% (95% confidence interval 47%...70%). Further genotyping of rs1049353 in 113 additional independent patients with AN and 178 normal weight controls could not substantiate the initial trend for association (p = 1.00).</p></sec><sec><title>Conclusion</title><p>As we found no evidence for an association of genetic variation in <italic>CNR1</italic>, <italic>FAAH, NAAA and MGLL </italic>with AN, we conclude that genetic variations in these genes do not play a major role in the etiology of AN in our study groups.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Anorexia nervosa (AN) is an eating disorder with unknown etiology. The multifactorial pathogenesis of AN has been emphasized in various studies [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. Accordingly, heritability estimates derived from twin studies revealed that 58&#x02013;76% of the variance of AN can be explained by genetic factors [<xref ref-type="bibr" rid="B4">4</xref>]. The highest incidence for the development of AN is around puberty and patients with AN are typically characterized by an abnormal eating behaviour with disturbances of attitudes towards body weight and shape [<xref ref-type="bibr" rid="B5">5</xref>]. Therefore, it is reasonable that genetic factors regulating food intake and body weight are implicated in the pathogenesis of AN [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>].</p><p>One of the endogenous systems that, due to its therapeutic potential in the treatment of obesity, recently reached scientific interest is the endocannabinoid system. Both exogenous (e.g. &#x00394;<sup>9</sup>-tetrahydrocannabinol) and endogenous cannabinoids (e.g. anandamide and 2-arachidonoylglycerol (2-AG)) stimulate food intake through activation of the cannabinoid receptor 1 (CNR1) [<xref ref-type="bibr" rid="B8">8</xref>]. In contrast, inhibition of CNR1 signalling through administration of the selective inverse agonist rimonabant (Acomplia<sup>&#x000ae;</sup>) decreases food intake in both rodents [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>] and humans [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. The endocannabinoid system further interacts with the leptinergic system; obese rodents with disturbed leptin signal transduction (<italic>ob/ob </italic>and <italic>db/db </italic>mice as well as <italic>fa/fa </italic>rats) show elevated levels of anandamide and 2-AG in the hypothalamus. Vice versa, leptin treatment of <italic>ob/ob </italic>mice decreased hypothalamic levels of both, anandamide and 2-AG [<xref ref-type="bibr" rid="B11">11</xref>]. Accordingly, compared to age matched normal weight controls, serum levels of anandamide are increased in patients with AN. Additionally, plasma levels of leptin are negatively correlated with anandamide in both, patients with AN and normal weight healthy controls [<xref ref-type="bibr" rid="B2">2</xref>]. In light of these observations, it has previously been suggested that the endocannabinoid system might be implicated in the etiology of AN, in particular through its interaction with the leptinergic system [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B7">7</xref>].</p><p>Hypoleptinemia is a cardinal feature of prolonged semi-starvation that entails various metabolic and neuroendocrine alterations which are typically observed in patients with acute AN [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B14">14</xref>] The most prominent neuroendocrine alterations mediated by semi-starvation induced hypoleptinemia include amenorrhea, osteopenia/osteoporosis, and alterations of the hypothalamic-pituitary-gonadal (HPG) and -adrenal (HPA) axis [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Additionally, several lines of evidence indicate that hypoleptinemia entails development of hyperactivity in patients with AN [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. However, the implication of the endocannabinoid system in body weight regulation together with its interaction with the leptinergic system makes it a plausible system implicated in the pathogenesis of AN [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B7">7</xref>].</p><p>The most prominent endocannabinoids are N-arachidonoylethanolamine (anandamide) [<xref ref-type="bibr" rid="B19">19</xref>] and 2-arachidonoylglycerol (2-AG) [<xref ref-type="bibr" rid="B20">20</xref>]. Both are synthesised through cells on demand and undergo a rapid degradation through specific hydrolases and lipases [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. The most prominent endocannabinoid degrading enzymes are the fatty acid amide hydrolase (FAAH), the N-acylethanolamine-hydrolyzing acid amidase (NAAA) and the monoglyceride lipase (MGLL) [<xref ref-type="bibr" rid="B23">23</xref>]. FAAH is a membrane-bound 60&#x02013;65 kDa protein that is widely distributed throughout the brain and the periphery [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. Under alkaline conditions, FAAH rapidly inhibits the orexigenic effects of anandamide by degrading it to ethanolamine and arachidonic acid [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. NAAA is an enzyme with similar function but has, in contrast to FAAH, its pH optimum at 4.5&#x02013;5 [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. The monoglyceride lipase (MGLL) is a serine hydrolase that hydrolyses 2-AG in glycerol and arachidonic acid [<xref ref-type="bibr" rid="B22">22</xref>]. As endocannabinoids stimulate food intake through activation of CNR1 and as FAAH, NAAA and MGLL counteract the orexigenic effects of endocannabinoids through their rapid degradation, genetic variation of <italic>CNR1 </italic>leading to decreased receptor signalling as well as genetic variation of <italic>FAAH, NAAA and MGLL </italic>leading to increased enzyme activity might be implicated in the etiology of AN.</p><p>We performed association studies to analyse whether allelic variation in <italic>CNR1</italic>, <italic>FAAH</italic>, <italic>NAAA </italic>and <italic>MGLL </italic>is related to the AN phenotype. We therefore genotyped the previously described (AAT)<sub>n </sub>repeat in the 3' flanking region of <italic>CNR1 </italic>as well as a total of 15 SNPs representative of regions with restricted haplotype diversity in <italic>CNR1 </italic>(rs2180619, rs806379, rs1535255, rs2023239 and rs1049353), <italic>FAAH </italic>(rs932816, rs324420, rs324419, rs2295632 and rs873978), <italic>NAAA </italic>(rs2292534, rs6532046, rs10518142 and rs874546) and <italic>MGLL </italic>(rs893294) in up to 91 German AN trios (patient with AN and both biological parents). Genotyping was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry or allele specific polymerase chain reaction (ARMS-PCR). The AAT<sub>14 </sub>repeat allele of <italic>CNR1 </italic>has recently been found to be associated with the binge eating/purging type of AN whereby the AAT<sub>13 </sub>repeat allele tended to be preferentially transmitted to patients with the restricting type of AN [<xref ref-type="bibr" rid="B29">29</xref>]. Furthermore, SNP rs324420 (c.385C/A) in the <italic>FAAH </italic>gene, leading to decreased enzyme activity and thus increased levels of endocannabinoids and presumably increased food intake, was recently found to be associated with obesity [<xref ref-type="bibr" rid="B30">30</xref>] and drug abuse [<xref ref-type="bibr" rid="B31">31</xref>]. The <italic>CNR1 </italic>haplotype comprising the minor alleles of SNP rs806379 (T-allele), rs1535255 (G-allele) and rs2023239 (C-allele) has further been shown to be associated with drug and alcohol abuse in European and African Americans [<xref ref-type="bibr" rid="B32">32</xref>].</p></sec><sec sec-type="methods"><title>Methods</title><p>The ascertainment strategy was previously described in detail [<xref ref-type="bibr" rid="B33">33</xref>]. Written informed consent was given by all participants and in the case of minors, by their parents. The study was approved by the ethics committees of the Universities of Marburg and Duisburg-Essen and carried out according to the Declaration of Helsinki.</p><p><italic>Study group 1 (AN trios) </italic>comprised 91 (3 male) patients with AN (mean age 15.72 &#x000b1; 2.04 years, mean BMI 15.42 &#x000b1; 2.39 kg/m<sup>2</sup>) and both biological parents (mean age 46.73 &#x000b1; 5.67, mean BMI 26.22 &#x000b1; 4.16 kg/m<sup>2</sup>).</p><p><italic>Study group 2 (cases and controls) </italic>included 204 patients with AN (113 patients with AN independent from study group 1). The 113 (7 male) independent patients included 65 (3 male) individuals with acute AN and 48 (4 male) individuals from a catamnestic study with a history of AN. The acute patients had a mean age of 22.47 &#x000b1; 11.67 years and a mean BMI of 14.81 &#x000b1; 2.29 kg/m<sup>2</sup>. The catamnestic individuals had a mean age of 33.60 &#x000b1; 7.22 years and a mean BMI of 20.78 &#x000b1; 2.05 kg/m<sup>2</sup>. In total, the 204 (10 male) patients had a mean age of 22.13 &#x000b1; 10.03 years, a mean BMI of 16.46 &#x000b1; 3.30 kg/m<sup>2</sup>. The control group comprised 178 healthy normal weight individuals with a mean age of 24.58 &#x000b1; 2.56 years and a mean BMI of 21.76 &#x000b1; 1.08 kg/m<sup>2</sup>. All patients with AN fulfilled the diagnostic criteria for AN according to the diagnostic and statistical manual of mental disorders (DSM-IV) [<xref ref-type="bibr" rid="B34">34</xref>].</p><p>Genotyping was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS, Sequenom, San Diego, CA). Only the <italic>CNR1 </italic>SNP rs1049353 was genotyped using ARMS-PCR as described previously [<xref ref-type="bibr" rid="B35">35</xref>]. The <italic>CNR1 </italic>(AAT) trinucleotide repeat was genotyped using 3730xl capillary sequencers (Applied Biosystems) and GeneMapper software (Version 4.0, Applied Biosystems). Primers for analyses of <italic>CNR1 </italic>variations were derived from genomic entry AL136096.<underline>7</underline>; rs1049353 F<sub>out</sub>: 5'-GGA CTC GGA CTG CCT GCA CAA A-3'; R<sub>out</sub>: 5'-AAA TTC TTT TCC TGT GCT GCC AGG G-3', F<sub>in</sub>: 5'-CAG AAA GCT GCA TCA AGA GCC CG-3', R<sub>in</sub>: 5'-GAC ATG GTT ACC TTG GCA ATC TTG CCT-3' (product size outer primers: 175 bp, G-allele: 120 bp, A-allele: 105 bp); (AAT) trinucleotide repeat: F (FAM-labelled): 5'-CCT TCT CCC AGC ACA ATC AT-3', R: 5'-TAC ATC TCG GTG TGT GAT GTT CC A TGT TCC-3' (PCR-product size based on genomic entry AL136096.7: 277 bp). SNP assays for analyses with MALDI-TOF mass spectrometry were designed with the SpectroDesigner software (Sequenom). For validity of genotypes, alleles were rated independently by at least two experienced individuals. Discrepancies were resolved unambiguously either by reaching consensus or by retyping.</p><p>The family-based association analyses were done applying transmission disequilibrium tests (TDT) [<xref ref-type="bibr" rid="B36">36</xref>] while the software FAMHAP (v16; <ext-link ext-link-type="uri" xlink:href="http://www.uni-bonn.de/~umte70e/becker.html"/>) was used to investigate the haplotypes consisting of the genotyped SNPs within the respective genes. Power considerations for the A-allele of rs1049353 were performed using the program Quanto (v 1.2.3; <ext-link ext-link-type="uri" xlink:href="http://hydra.usc.edu/gxe"/>) at the one-sided significance level of 0.05. Here, we assumed an AN prevalence of 0.5% and an allele frequency of 0.26 (accoding to <ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org"/>, CEU sample). Exact Cochran-Armitage trend test, implemented in SAS, was applied to test for association of the <italic>CNR1 </italic>SNP rs1049353 in case-control data. If not indicated otherwise, all reported p-values are two-sided and were not corrected for multiple testing as none of the null hypotheses was rejected. A significance level of &#x003b1; = 0.05 (two-sided) was applied.</p></sec><sec><title>Results</title><p>The Transmission-Disequilibrium Test (TDT) revealed no indication for an association of the analysed SNPs or the (AAT)<sub>n </sub>repeat with AN (Table <xref ref-type="table" rid="T1">1</xref>). For the A-allele of the <italic>CNR1 </italic>SNP rs1049353 the lowest p-value was 0.11 for an estimated transmission rate of 59% (95% confidence interval 47%...70%). Applying conditional logistic regression on the trio data, we obtained a multiplicative OR of the A-allele at 1.43 (95% confidence interval 0.91...2.25). Hence, in assuming a true effect of such size the power of our consecutive case-control study comprising 113 additional independent patients with AN and 178 normal weight controls would be about 60%. The initial finding, however, could not be substantiated by the case-control approach (exact p = 1.00). Similarly, a combined case-control analysis including the 91 patients from the family-trios (204 patients with AN and 178 controls) revealed no association of the A-allele of rs1049353 with the AN phenotype (exact p = 0.27; multiplicative OR 1.20; 95% CI 0.88...1.65).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Genotypes and TDT results of the analysed variants in <italic>CNR1</italic>. <italic>NAAA </italic>and <italic>MGLL </italic>in the AN trios</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Gene</bold></td><td align="center"><bold>SNP<sup>1,2</sup></bold></td><td align="center"><bold>Alleles<sup>3 </sup>major/minor</bold></td><td align="center"><bold>Location Exchange</bold></td><td align="center"><bold>N<sup>4</sup></bold></td><td align="center"><bold>Genotypes (%)<sup>5</sup></bold></td><td align="center"><bold>Allele frequ.<sup>6</sup></bold></td><td align="center"><bold>Transm. rate<sup>7</sup></bold></td><td align="center"><bold>p-value<sup>8</sup></bold></td></tr></thead><tbody><tr><td></td><td></td><td></td><td></td><td></td><td align="center">A/A 26 (42.62)</td><td align="center">A: 0.64</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">A/G 26 (42.62)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>CNR1</italic></td><td align="center">rs2180619</td><td align="center">-22,959A/G</td><td align="center">Putative promoter</td><td align="center">61</td><td align="center">G/G 9 (14.75)</td><td align="center">G: 0.36</td><td align="center">0.49 (G)</td><td align="center">1.00</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">A/A 16 (26.23)</td><td align="center">A: 0.55</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">A/T 35 (57.38)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>CNR1</italic></td><td align="center">rs806379</td><td align="center">-6,274A/T</td><td align="center">Intron 2</td><td align="center">61</td><td align="center">T/T 10 (16.39)</td><td align="center">T: 0.45</td><td align="center">0.52 (T)</td><td align="center">0.90</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">T/T 43 (70.49)</td><td align="center">T: 0.84</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">T/G 16 (26.23)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>CNR1</italic></td><td align="center">rs1535255</td><td align="center">-6,215T/G</td><td align="center">Intron 2</td><td align="center">61</td><td align="center">G/G 2 (3.28)</td><td align="center">G: 0.16</td><td align="center">0.50 (G)</td><td align="center">1.00</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">T/T 43 (70.49)</td><td align="center">T: 0.84</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">T/C 16 (26.23)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>CNR1</italic></td><td align="center">rs2023239</td><td align="center">-5,489T/C</td><td align="center">Exon 3<break/>Non-coding</td><td align="center">61</td><td align="center">C/C 2 (3.28)</td><td align="center">C: 0.16</td><td align="center">0.50 (C)</td><td align="center">1.00</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/G 38 (41.76)</td><td align="center">G: 0.65</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/A 43 (47.25)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>CNR1</italic></td><td align="center">rs1049353</td><td align="center">1,359G/A</td><td align="center">Exon 4<break/>Thr453Thr</td><td align="center">91</td><td align="center">A/A 10 (10.99)</td><td align="center">A: 0.35</td><td align="center">0.59 (A)</td><td align="center">0.11</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/G 33 (54.10)</td><td align="center">G: 0.75</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/A 26 (42.62)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>FAAH</italic></td><td align="center">rs932816</td><td align="center">-272G/A</td><td align="center">Putative<break/>promoter</td><td align="center">61</td><td align="center">A/A 2 (3.28)</td><td align="center">A: 0.25</td><td align="center">0.39 (A)</td><td align="center">0.13</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">C/C 40 (66.67)</td><td align="center">C: 0.80</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">C/A 16 (26.67)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>FAAH</italic></td><td align="center">rs324420</td><td align="center">10,741C/A</td><td align="center">Exon 3<break/>Thr129Pro</td><td align="center">60</td><td align="center">A/A 4 (6.67)</td><td align="center">A: 0.20</td><td align="center">0.56 (A)</td><td align="center">0.61</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/G 49 (80.33)</td><td align="center">G: 0.89</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/A 11 (18.03)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>FAAH</italic></td><td align="center">rs324419</td><td align="center">11,966G/A</td><td align="center">Exon 7<break/>Cys299Cys</td><td align="center">61</td><td align="center">A/A 1 (1.64)</td><td align="center">A: 0.11</td><td align="center">0.59 (A)</td><td align="center">0.52</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/G 60 (98.36)</td><td align="center">G: 0.99</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/A 1 (1.64)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>FAAH</italic></td><td align="center">rs873978</td><td align="center">13,883G/A</td><td align="center">Intron 7</td><td align="center">61</td><td align="center">A/A 0 (0.00)</td><td align="center">A: 0.01</td><td align="center">1.00 (A)</td><td align="center">1.00</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">C/C 34 (56.67)</td><td align="center">C: 0.73</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">C/A 20 (33.33)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>FAAH</italic></td><td align="center">rs2295632</td><td align="center">19,542C/A</td><td align="center">3'UTR</td><td align="center">60</td><td align="center">A/A 6 (10.0)</td><td align="center">A: 0.27</td><td align="center">0.42 (A)</td><td align="center">0.42</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/G 34 (56.67)</td><td align="center">G: 0.75</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/A 22 (36.67)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>NAAA</italic></td><td align="center">rs2292534</td><td align="center">368A/G</td><td align="center">Intron 1</td><td align="center">60</td><td align="center">A/A 4 (6.67)</td><td align="center">A: 0.25</td><td align="center">0.57 (A)</td><td align="center">0.42</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">A/A 38 (62.30)</td><td align="center">A: 0.78</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">A/T 19 (31.15)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>NAAA</italic></td><td align="center">rs4859567</td><td align="center">9,263A/T</td><td align="center">Intron 3</td><td align="center">61</td><td align="center">T/T 4 (6.56)</td><td align="center">T: 0.22</td><td align="center">0.43 (T)</td><td align="center">0.42</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/G 36 (60.00)</td><td align="center">G: 0.78</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">G/T 21 (35.00)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>NAAA</italic></td><td align="center">rs10518142</td><td align="center">19,229G/T</td><td align="center">Intron 5</td><td align="center">60</td><td align="center">T/T 3 (5.00)</td><td align="center">T: 0.22</td><td align="center">0.63 (T)</td><td align="center">0.13</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">C/C 22 (36.07)</td><td align="center">C: 0.61</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">C/T 31 (50.82)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>NAAA</italic></td><td align="center">rs6819442</td><td align="center">22,995C/T</td><td align="center">Intron 9</td><td align="center">61</td><td align="center">T/T 8 (13.11)</td><td align="center">T: 0.39</td><td align="center">0.56 (T)</td><td align="center">0.42</td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">T/T 36 (59.02)</td><td align="center">T: 0.75</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td align="center">T/A 19 (31.15)</td><td></td><td></td><td></td></tr><tr><td align="center"><italic>MGLL</italic></td><td align="center">rs893294</td><td align="center">121,143T/A</td><td align="center">Intron 8</td><td align="center">61</td><td align="center">A/A 6 (9.84)</td><td align="center">A: 0.25</td><td align="center">0.54 (A)</td><td align="center">0.75</td></tr></tbody></table><table-wrap-foot><p><sup>1 </sup>All SNPs were tested for Hardy-Weinberg equilibrium (exact p &#x02265; 0.05); <sup>2 </sup>The TGC haplotype comprises the minor alleles of rs806379, rs1535255, and rs2023239; <sup>3 </sup>Numbers are given according to genomic entry AL136096.7 and the translation start codon (nt+1 is the A of ATG); SNP alleles correspond to dbSNP <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/"/>; <sup>4 </sup>Number of anorexia nervosa trios genotyped; <sup>5 </sup>Genotype frequencies in the patients with AN; <sup>6 </sup>Allele frequencies in the patients with AN; <sup>7 </sup>Transmission rate of the minor alleles; <sup>8 </sup>for TDT</p></table-wrap-foot></table-wrap><p>The <italic>CNR1 </italic>haplotype comprising the minor alleles of rs806379, rs1535255 and rs2023239 (TGC), previously found to be associated with polysubstance abuse in European and African Americans [<xref ref-type="bibr" rid="B32">32</xref>], revealed likewise no evidence for an association with AN in our study groups. The allele frequencies of the <italic>CNR1 </italic>AAT trinucleotide repeat were in accordance to previous results [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. However, the AAT<sub>13 </sub>and AAT<sub>14 </sub>repeat alleles, previously found to be preferentially transmitted to the restricting and binge eating/purging type of AN, respectively, [<xref ref-type="bibr" rid="B29">29</xref>] did not indicate evidence for an association with AN in our samples (the global test for transmission disequilibrium indicated p = 0.35). Further haplotype analyses resulted in lack of transmission disequilibrium for all haplotypes, including those solely comprising frequently transmitted alleles (p of global test for haplotypes of five <italic>CNR1 </italic>SNPs: 0.66; five <italic>FAAH </italic>SNPs: 0.45 and four <italic>NAAA </italic>SNPs: 0.72).</p></sec><sec><title>Discussion</title><p>We observed no evidence for a transmission disequilibrium for any of the 15 analysed SNPs in <italic>CNR1</italic>, <italic>FAAH, NAAA or MGLL </italic>as assessed by the TDT. The strongest effect with an estimated transmission rate of 59% hinting at a preferential transmission of the <italic>CNR1 </italic>rs1049353 A-allele to patients with AN was not substantiated in a subsequent case-control study comprising 113 independent patients with AN and 178 healthy controls. Also, combining the 113 independent patients with AN with the 91 patients from study group 1 did not alter this lack of evidence for an association of the rs1049353 A-allele to patients with AN. Contrary to our initial expectation of an effect size of 1.43 estimated from the trio sample, the true effect of this allele may be more moderate to be detected by our, even pooled, relatively small case-control sample.</p><p>Even though the <italic>CNR1 </italic>SNP rs1049353 has not been analysed in patients with AN before, the G-allele of rs1049353 was recently found to be associated with obesity in a small case-control study comprising obese and normal weight Italians [<xref ref-type="bibr" rid="B39">39</xref>]. However, several other studies could not confirm this finding [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>]. The <italic>CNR1 </italic>TGC haplotype previously found to be associated with polysubstance abuse in European and African Americans [<xref ref-type="bibr" rid="B32">32</xref>] revealed likewise no evidence for a transmission disequilibrium in our samples. Also the AAT<sub>14 </sub>and AAT<sub>13 </sub>repeat alleles of <italic>CNR1</italic>, which has previously been reported to be preferentially transmitted in patients with the binge eating/purging or restricting type of AN, respectively, were not found to be preferentially transmitted to patients with AN in our study. However, it has to be considered that the moderate to low sample size used in this study might have contributed to the observed lack of association. Additionally, it can not be ruled out that other variants, that are not in linkage disequilibrium with the here analysed variants, might contribute to the pathogenesis of AN.</p><p>Exogenous and endogenous cannabinoids stimulate food intake and promote weight gain in both, rodents [<xref ref-type="bibr" rid="B42">42</xref>] and humans [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. Oral application of &#x00394;<sup>9</sup>-THC further increases food intake and entails weight restoration in cachectic patients receiving cancer chemotherapy [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>]. Only one small trial comprising 11 (of which three dropped out) patients with AN has focused on body weight gain after treatment with &#x00394;<sup>9</sup>-THC and found no effect of oral application of &#x00394;<sup>9</sup>-THC in doses up to 30 mg/day on body weight gain after four weeks of treatment [<xref ref-type="bibr" rid="B45">45</xref>]. However, in light of the small sample size, this observation has to be regarded with caution, especially as THC induced weight gain was compared to diazepam, for which animal studies also indicate a stimulation of body weight gain after its application [<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>].</p><p>Various association studies for AN have, with only limited success, focused on genes implicated in the regulation of food intake, as e.g. on the genes coding for leptin [<xref ref-type="bibr" rid="B48">48</xref>], the leptin receptor (<italic>ObRb</italic>) [<xref ref-type="bibr" rid="B49">49</xref>], ghrelin [<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B51">51</xref>], the brain derived neurotrophic factor (<italic>BDNF</italic>) [<xref ref-type="bibr" rid="B52">52</xref>-<xref ref-type="bibr" rid="B55">55</xref>] or the tumor necrosis factor-alpha (<italic>TNF-&#x003b1;</italic>) [<xref ref-type="bibr" rid="B56">56</xref>]. Most of the respective studies yielded negative results. However, Ribases et al. (2003) reported strong association of the Val66Met polymorphism of <italic>BDNF </italic>with the restricting type of AN [<xref ref-type="bibr" rid="B52">52</xref>]. Additionally, this variant was associated with minimum BMI in these patients [<xref ref-type="bibr" rid="B52">52</xref>]. Replication analyses of this variant in 1,142 Caucasian patients with eating disorders from five European countries confirmed the association of this variant with all eating disorder subtypes including AN, AN-restricting type, AN-binge-eating/purging type and BN [<xref ref-type="bibr" rid="B53">53</xref>]. However, not all studies were able to confirm this finding [<xref ref-type="bibr" rid="B55">55</xref>].</p></sec><sec><title>Conclusion</title><p>In summary, we did not find evidence for an association of the (AAT)<sub>n </sub>repeat and several SNPs in <italic>CNR1</italic>, <italic>FAAH, NAAA and MGLL </italic>with AN in our samples. We thus conclude that the here analysed variations in <italic>CNR1, FAAH, NAAA </italic>and <italic>MGLL </italic>at least do not seem to play a major role in the genetic etiology of AN in our study groups.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>TDM carried out the allele specific PCR, participated in design and interpretation of data and drafted the manuscript. KR and JK carried out the capillary sequencing. KR further participated in design and interpretation of data and revised the manuscript critically. GB participated in the design and interpretation of data. TTN and AS performed the statistical analysis under supervision of HS. WH and BH-D participated in patient recruitment and interpretation of data. PL and TM carried out the molecular genetic studies using MALDI-TOF mass spectrometry. JH and AH conceived the design and participated in coordination and interpretation of data; helped to draft the manuscript and revised it critically.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was supported by grants from the Federal Ministry of Education and Research (NGFN2: 01GS0482, 01GS0483; NGFN<sup>Plus</sup>: 01GS0820), the European Union (FP6 LSHMCT-2003-503041) and the Deutsche Forschungsgemeinschaft (DFG; HE 1446/4-1). The skillful technical assistance of Jitka Andrae is highly appreciated.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Friedel</surname><given-names>S</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>Genetic risk factors in eating disorders</article-title><source>Am J Pharmacogenomics</source><year>2004</year><volume>4</volume><fpage>209</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">15287815</pub-id><pub-id pub-id-type="doi">10.2165/00129785-200404040-00001</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monteleone</surname><given-names>P</given-names></name><name><surname>Matias</surname><given-names>I</given-names></name><name><surname>Martiadis</surname><given-names>V</given-names></name><name><surname>De Petrocellis</surname><given-names>L</given-names></name><name><surname>Maj</surname><given-names>M</given-names></name><name><surname>Di Marzo</surname><given-names>V</given-names></name></person-group><article-title>Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa</article-title><source>Neuropsychopharmacology</source><year>2005</year><volume>30</volume><fpage>1216</fpage><lpage>1221</lpage><pub-id pub-id-type="pmid">15841111</pub-id><pub-id pub-id-type="doi">10.1038/sj.npp.1300695</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Keski-Rahkonen</surname><given-names>A</given-names></name><name><surname>Klump</surname><given-names>KL</given-names></name><name><surname>Reichborn-Kjennerud</surname><given-names>T</given-names></name><name><surname>Mazzeo</surname><given-names>SE</given-names></name><name><surname>Wade</surname><given-names>TD</given-names></name></person-group><article-title>Genetic epidemiology, endophenotypes, and eating disorder classification</article-title><source>Int J Eat Disord</source><year>2007</year><volume>40</volume><fpage>S52</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">17573683</pub-id><pub-id pub-id-type="doi">10.1002/eat.20398</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klump</surname><given-names>KL</given-names></name><name><surname>Miller</surname><given-names>KB</given-names></name><name><surname>Keel</surname><given-names>PK</given-names></name><name><surname>McGue</surname><given-names>M</given-names></name><name><surname>Iacono</surname><given-names>WG</given-names></name></person-group><article-title>Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample</article-title><source>Psychol Med</source><year>2001</year><volume>31</volume><fpage>737</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">11352375</pub-id><pub-id pub-id-type="doi">10.1017/S0033291701003725</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Muller</surname><given-names>TD</given-names></name><name><surname>Holtkamp</surname><given-names>K</given-names></name><name><surname>Herpertz-Dahlmann</surname><given-names>B</given-names></name></person-group><article-title>The role of leptin in anorexia nervosa: clinical implications</article-title><source>Mol Psychiatry</source><year>2007</year><volume>12</volume><fpage>23</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">17060920</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4001909</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halmi</surname><given-names>KA</given-names></name></person-group><article-title>Eating disorders in females: genetics, pathophysiology, and treatment</article-title><source>J Pediatr Endocrinol Metab</source><year>2002</year><volume>15</volume><fpage>1379</fpage><lpage>1386</lpage><pub-id pub-id-type="pmid">12510994</pub-id></citation></ref><ref id="B7"><citation citation-type="other"><person-group person-group-type="author"><name><surname>St&#x000f8;ving</surname><given-names>RK</given-names></name><name><surname>Andries</surname><given-names>A</given-names></name><name><surname>Brixen</surname><given-names>K</given-names></name><name><surname>Flyvbjerg</surname><given-names>A</given-names></name><name><surname>H&#x000f8;rder</surname><given-names>K</given-names></name><name><surname>Frystyk</surname><given-names>J</given-names></name></person-group><article-title>Leptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa</article-title><source>J Psychiatr Res</source><year>2008</year></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Marzo</surname><given-names>V</given-names></name><name><surname>Bifulco</surname><given-names>M</given-names></name><name><surname>De Petrocellis</surname><given-names>L</given-names></name></person-group><article-title>The endocannabinoid system and its therapeutic exploitation</article-title><source>Nat Rev Drug Discov</source><year>2004</year><volume>3</volume><fpage>771</fpage><lpage>784</lpage><pub-id pub-id-type="pmid">15340387</pub-id><pub-id pub-id-type="doi">10.1038/nrd1495</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>G</given-names></name><name><surname>Agabio</surname><given-names>R</given-names></name><name><surname>Diaz</surname><given-names>G</given-names></name><name><surname>Lobina</surname><given-names>C</given-names></name><name><surname>Reali</surname><given-names>R</given-names></name><name><surname>Gessa</surname><given-names>GL</given-names></name></person-group><article-title>Appetite suppression and weight loss after the cannabinoid antagonist SR 141716</article-title><source>Life Sci</source><year>1998</year><volume>63</volume><fpage>PL113</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">9718088</pub-id><pub-id pub-id-type="doi">10.1016/S0024-3205(98)00322-1</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YL</given-names></name><name><surname>Connoley</surname><given-names>IP</given-names></name><name><surname>Wilson</surname><given-names>CA</given-names></name><name><surname>Stock</surname><given-names>MJ</given-names></name></person-group><article-title>Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice</article-title><source>Int J Obes (Lond)</source><year>2005</year><volume>29</volume><fpage>183</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">15558076</pub-id><pub-id pub-id-type="doi">10.1038/sj.ijo.0802847</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Marzo</surname><given-names>V</given-names></name><name><surname>Goparaju</surname><given-names>SK</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>B&#x000e1;tkai</surname><given-names>S</given-names></name><name><surname>J&#x000e1;rai</surname><given-names>Z</given-names></name><name><surname>Fezza</surname><given-names>F</given-names></name><name><surname>Miura</surname><given-names>GI</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name><name><surname>Sugiura</surname><given-names>T</given-names></name><name><surname>Kunos</surname><given-names>G</given-names></name></person-group><article-title>Leptin-regulated endocannabinoids are involved in maintaining food intake</article-title><source>Nature</source><year>2001</year><volume>410</volume><fpage>822</fpage><lpage>825</lpage><pub-id pub-id-type="pmid">11298451</pub-id><pub-id pub-id-type="doi">10.1038/35071088</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Gaal</surname><given-names>LF</given-names></name><name><surname>Rissanen</surname><given-names>AM</given-names></name><name><surname>Scheen</surname><given-names>AJ</given-names></name><name><surname>Ziegler</surname><given-names>O</given-names></name><name><surname>R&#x000f6;ssner</surname><given-names>S</given-names></name><collab>RIO-Europe Study Group</collab></person-group><article-title>Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study</article-title><source>Lancet</source><year>2005</year><volume>365</volume><fpage>1389</fpage><lpage>1397</lpage><pub-id pub-id-type="pmid">15836887</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(05)66374-X</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Despr&#x000e9;s</surname><given-names>JP</given-names></name><name><surname>Golay</surname><given-names>A</given-names></name><name><surname>Sj&#x000f6;str&#x000f6;m</surname><given-names>L</given-names></name><collab>Rimonabant in Obesity-Lipids Study Group</collab></person-group><article-title>Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia</article-title><source>N Engl J Med</source><year>2005</year><volume>353</volume><fpage>2121</fpage><lpage>2134</lpage><pub-id pub-id-type="pmid">16291982</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa044537</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Exner</surname><given-names>C</given-names></name><name><surname>Hebebrand</surname><given-names>K</given-names></name><name><surname>Holtkamp</surname><given-names>C</given-names></name><name><surname>Casper</surname><given-names>RC</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Herpertz-Dahlmann</surname><given-names>B</given-names></name><name><surname>Klingenspor</surname><given-names>M</given-names></name></person-group><article-title>Hyperactivity in patients with anorexia nervosa and in semistarved rats: evidence for a pivotal role of hypoleptinemia</article-title><source>Physiol Behav</source><year>2003</year><volume>79</volume><fpage>25</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">12818707</pub-id><pub-id pub-id-type="doi">10.1016/S0031-9384(03)00102-1</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Exner</surname><given-names>C</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Wewetzer</surname><given-names>C</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Herpertz</surname><given-names>S</given-names></name><name><surname>Schweiger</surname><given-names>U</given-names></name><name><surname>Blum</surname><given-names>WF</given-names></name><name><surname>Preibisch</surname><given-names>G</given-names></name><name><surname>Heldmaier</surname><given-names>G</given-names></name><name><surname>Klingenspor</surname><given-names>M</given-names></name></person-group><article-title>Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa</article-title><source>Mol Psychiatry</source><year>2000</year><volume>5</volume><fpage>476</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">11032380</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4000771</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holtkamp</surname><given-names>K</given-names></name><name><surname>Herpertz-Dahlmann</surname><given-names>B</given-names></name><name><surname>Mika</surname><given-names>C</given-names></name><name><surname>Heer</surname><given-names>M</given-names></name><name><surname>Heussen</surname><given-names>N</given-names></name><name><surname>Fichter</surname><given-names>M</given-names></name><name><surname>Herpertz</surname><given-names>S</given-names></name><name><surname>Senf</surname><given-names>W</given-names></name><name><surname>Blum</surname><given-names>WF</given-names></name><name><surname>Schweiger</surname><given-names>U</given-names></name><name><surname>Warnke</surname><given-names>A</given-names></name><name><surname>Ballauff</surname><given-names>A</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa</article-title><source>J Clin Endocrinol Metab</source><year>2003</year><volume>88</volume><fpage>5169</fpage><lpage>5174</lpage><pub-id pub-id-type="pmid">14602745</pub-id><pub-id pub-id-type="doi">10.1210/jc.2003-030569</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holtkamp</surname><given-names>K</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Herpertz-Dahlmann</surname><given-names>B</given-names></name></person-group><article-title>The contribution of anxiety and food restriction on physical activity levels in acute anorexia nervosa</article-title><source>Int J Eat Disord</source><year>2004</year><volume>36</volume><fpage>163</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">15282686</pub-id><pub-id pub-id-type="doi">10.1002/eat.20035</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holtkamp</surname><given-names>K</given-names></name><name><surname>Herpertz-Dahlmann</surname><given-names>B</given-names></name><name><surname>Hebebrand</surname><given-names>K</given-names></name><name><surname>Mika</surname><given-names>C</given-names></name><name><surname>Kratzsch</surname><given-names>J</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>Physical activity and restlessness correlate with leptin levels in patients with adolescent anorexia nervosa</article-title><source>Biol Psychiatry</source><year>2006</year><volume>60</volume><fpage>311</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">16376860</pub-id><pub-id pub-id-type="doi">10.1016/j.biopsych.2005.11.001</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devane</surname><given-names>WA</given-names></name><name><surname>Hanus</surname><given-names>L</given-names></name><name><surname>Breuer</surname><given-names>A</given-names></name><name><surname>Pertwee</surname><given-names>RG</given-names></name><name><surname>Stevenson</surname><given-names>LA</given-names></name><name><surname>Griffin</surname><given-names>G</given-names></name><name><surname>Gibson</surname><given-names>D</given-names></name><name><surname>Mandelbaum</surname><given-names>A</given-names></name><name><surname>Etinger</surname><given-names>A</given-names></name><name><surname>Mechoulam</surname><given-names>R</given-names></name></person-group><article-title>Isolation and structure of a brain constituent that binds to the cannabinoid receptor</article-title><source>Science</source><year>1992</year><volume>258</volume><fpage>1946</fpage><lpage>1949</lpage><pub-id pub-id-type="pmid">1470919</pub-id><pub-id pub-id-type="doi">10.1126/science.1470919</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Sukagawa</surname><given-names>A</given-names></name><name><surname>Nakane</surname><given-names>S</given-names></name><name><surname>Shinoda</surname><given-names>A</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Yamashita</surname><given-names>A</given-names></name><name><surname>Waku</surname><given-names>K</given-names></name></person-group><article-title>2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain</article-title><source>Biochem Biophys Res Commun</source><year>1995</year><volume>215</volume><fpage>89</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">7575630</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.1995.2437</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Marzo</surname><given-names>V</given-names></name></person-group><article-title>Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators</article-title><source>Life Sci</source><year>1999</year><volume>65</volume><fpage>645</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">10462065</pub-id><pub-id pub-id-type="doi">10.1016/S0024-3205(99)00287-8</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dinh</surname><given-names>TP</given-names></name><name><surname>Freund</surname><given-names>TF</given-names></name><name><surname>Piomelli</surname><given-names>D</given-names></name></person-group><article-title>A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation</article-title><source>Chem Phys Lipids</source><year>2002</year><volume>121</volume><fpage>149</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">12505697</pub-id><pub-id pub-id-type="doi">10.1016/S0009-3084(02)00150-0</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puffenbarger</surname><given-names>RA</given-names></name></person-group><article-title>Molecular biology of the enzymes that degrade endocannabinoids</article-title><source>Curr Drug Targets CNS Neurol Disord</source><year>2005</year><volume>4</volume><fpage>625</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">16375680</pub-id><pub-id pub-id-type="doi">10.2174/156800705774933050</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hillard</surname><given-names>CJ</given-names></name><name><surname>Wilkison</surname><given-names>DM</given-names></name><name><surname>Edgemond</surname><given-names>WS</given-names></name><name><surname>Campbell</surname><given-names>WB</given-names></name></person-group><article-title>Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain</article-title><source>Biochim Biophys Acta</source><year>1995</year><volume>1257</volume><fpage>249</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">7647100</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cravatt</surname><given-names>BF</given-names></name><name><surname>Giang</surname><given-names>DK</given-names></name><name><surname>Mayfield</surname><given-names>SP</given-names></name><name><surname>Boger</surname><given-names>DL</given-names></name><name><surname>Lerner</surname><given-names>RA</given-names></name><name><surname>Gilula</surname><given-names>NB</given-names></name></person-group><article-title>Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides</article-title><source>Nature</source><year>1996</year><volume>384</volume><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">8900284</pub-id><pub-id pub-id-type="doi">10.1038/384083a0</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cravatt</surname><given-names>BF</given-names></name><name><surname>Demarest</surname><given-names>K</given-names></name><name><surname>Patricelli</surname><given-names>MP</given-names></name><name><surname>Bracey</surname><given-names>MH</given-names></name><name><surname>Giang</surname><given-names>DK</given-names></name><name><surname>Martin</surname><given-names>BR</given-names></name><name><surname>Lichtman</surname><given-names>AH</given-names></name></person-group><article-title>Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>9371</fpage><lpage>9376</lpage><pub-id pub-id-type="pmid">11470906</pub-id><pub-id pub-id-type="doi">10.1073/pnas.161191698</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsuboi</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>YX</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name><name><surname>Araki</surname><given-names>N</given-names></name><name><surname>Tonai</surname><given-names>T</given-names></name><name><surname>Ueda</surname><given-names>N</given-names></name></person-group><article-title>Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>11082</fpage><lpage>11092</lpage><pub-id pub-id-type="pmid">15655246</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M413473200</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsuboi</surname><given-names>K</given-names></name><name><surname>Takezaki</surname><given-names>N</given-names></name><name><surname>Ueda</surname><given-names>N</given-names></name></person-group><article-title>The N-acylethanolamine-hydrolyzing acid amidase (NAAA)</article-title><source>Chem Biodivers</source><year>2007</year><volume>4</volume><fpage>1914</fpage><lpage>1925</lpage><pub-id pub-id-type="pmid">17712833</pub-id><pub-id pub-id-type="doi">10.1002/cbdv.200790159</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siegfried</surname><given-names>Z</given-names></name><name><surname>Kanyas</surname><given-names>K</given-names></name><name><surname>Latzer</surname><given-names>Y</given-names></name><name><surname>Karni</surname><given-names>O</given-names></name><name><surname>Bloch</surname><given-names>M</given-names></name><name><surname>Lerer</surname><given-names>B</given-names></name><name><surname>Berry</surname><given-names>EM</given-names></name></person-group><article-title>Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes</article-title><source>Am J Med Genet B Neuropsychiatr Genet</source><year>2004</year><volume>125B</volume><fpage>126</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">14755457</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.b.20089</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sipe</surname><given-names>JC</given-names></name><name><surname>Waalen</surname><given-names>J</given-names></name><name><surname>Gerber</surname><given-names>A</given-names></name><name><surname>Beutler</surname><given-names>E</given-names></name></person-group><article-title>Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)</article-title><source>Int J Obes (Lond)</source><year>2005</year><volume>29</volume><fpage>755</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">15809662</pub-id><pub-id pub-id-type="doi">10.1038/sj.ijo.0802954</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sipe</surname><given-names>JC</given-names></name><name><surname>Chiang</surname><given-names>K</given-names></name><name><surname>Gerber</surname><given-names>AL</given-names></name><name><surname>Beutler</surname><given-names>E</given-names></name><name><surname>Cravatt</surname><given-names>BF</given-names></name></person-group><article-title>A missense mutation in human fatty acid amide hydrolase associated with problem drug use</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>8394</fpage><lpage>8399</lpage><pub-id pub-id-type="pmid">12060782</pub-id><pub-id pub-id-type="doi">10.1073/pnas.082235799</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>PW</given-names></name><name><surname>Ishiguro</surname><given-names>H</given-names></name><name><surname>Ohtsuki</surname><given-names>T</given-names></name><name><surname>Hess</surname><given-names>J</given-names></name><name><surname>Carillo</surname><given-names>F</given-names></name><name><surname>Walther</surname><given-names>D</given-names></name><name><surname>Onaivi</surname><given-names>ES</given-names></name><name><surname>Arinami</surname><given-names>T</given-names></name><name><surname>Uhl</surname><given-names>GR</given-names></name></person-group><article-title>Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse</article-title><source>Mol Psychiatry</source><year>2004</year><volume>9</volume><fpage>916</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">15289816</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4001560</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Lentes</surname><given-names>KU</given-names></name><name><surname>Rosenkranz</surname><given-names>K</given-names></name><name><surname>Barth</surname><given-names>N</given-names></name><name><surname>Roth</surname><given-names>H</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Hennighausen</surname><given-names>K</given-names></name><name><surname>Coners</surname><given-names>H</given-names></name><name><surname>Wurmser</surname><given-names>H</given-names></name><name><surname>Jacob</surname><given-names>K</given-names></name><name><surname>R&#x000f6;mer</surname><given-names>G</given-names></name><name><surname>Winnikes</surname><given-names>U</given-names></name><name><surname>Mayer</surname><given-names>H</given-names></name><name><surname>Herzog</surname><given-names>W</given-names></name><name><surname>Lehmkuhl</surname><given-names>G</given-names></name><name><surname>Poustka</surname><given-names>F</given-names></name><name><surname>Schmidt</surname><given-names>MH</given-names></name><name><surname>Blum</surname><given-names>WF</given-names></name><name><surname>Pirke</surname><given-names>KM</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>H</given-names></name><name><surname>Grzeschik</surname><given-names>KH</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>Beta 3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa</article-title><source>Int J Obes Relat Metab Disord</source><year>1997</year><volume>21</volume><fpage>224</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">9080262</pub-id><pub-id pub-id-type="doi">10.1038/sj.ijo.0800391</pub-id></citation></ref><ref id="B34"><citation citation-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group><source>Diagnostic and statistical manual of mental disorders (DSM-IV)</source><year>1994</year><publisher-name>Washington, DC</publisher-name><fpage>539</fpage><lpage>549</lpage></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>TD</given-names></name><name><surname>Reichwald</surname><given-names>K</given-names></name><name><surname>Wermter</surname><given-names>AK</given-names></name><name><surname>Br&#x000f6;nner</surname><given-names>G</given-names></name><name><surname>Nguyen</surname><given-names>TT</given-names></name><name><surname>Friedel</surname><given-names>S</given-names></name><name><surname>Koberwitz</surname><given-names>K</given-names></name><name><surname>Engeli</surname><given-names>S</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>H</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name></person-group><article-title>No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents</article-title><source>Mol Genet Metab</source><year>2007</year><volume>90</volume><fpage>429</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">17292652</pub-id><pub-id pub-id-type="doi">10.1016/j.ymgme.2007.01.002</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spielman</surname><given-names>RS</given-names></name><name><surname>McGinnis</surname><given-names>RE</given-names></name><name><surname>Ewens</surname><given-names>WJ</given-names></name></person-group><article-title>Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM)</article-title><source>Am J Hum Genet</source><year>1993</year><volume>52</volume><fpage>506</fpage><lpage>516</lpage><pub-id pub-id-type="pmid">8447318</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>DE</given-names></name><name><surname>Muhleman</surname><given-names>D</given-names></name><name><surname>Gade</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>P</given-names></name><name><surname>Verde</surname><given-names>R</given-names></name><name><surname>Saucier</surname><given-names>G</given-names></name><name><surname>MacMurray</surname><given-names>J</given-names></name></person-group><article-title>Cannabinoid receptor gene (CNR1): association with i.v. drug use</article-title><source>Mol Psychiatry</source><year>1997</year><volume>2</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">9106242</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4000247</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Covault</surname><given-names>J</given-names></name><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Kranzler</surname><given-names>H</given-names></name></person-group><article-title>Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence</article-title><source>Mol Psychiatry</source><year>2001</year><volume>6</volume><fpage>501</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">11526463</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4000925</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gazzerro</surname><given-names>P</given-names></name><name><surname>Caruso</surname><given-names>MG</given-names></name><name><surname>Notarnicola</surname><given-names>M</given-names></name><name><surname>Misciagna</surname><given-names>G</given-names></name><name><surname>Guerra</surname><given-names>V</given-names></name><name><surname>Laezza</surname><given-names>C</given-names></name><name><surname>Bifulco</surname><given-names>M</given-names></name></person-group><article-title>Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population</article-title><source>Int J Obes (Lond)</source><year>2007</year><volume>31</volume><fpage>908</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">17160086</pub-id><pub-id pub-id-type="doi">10.1038/sj.ijo.0803510</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peeters</surname><given-names>A</given-names></name><name><surname>Beckers</surname><given-names>S</given-names></name><name><surname>Mertens</surname><given-names>I</given-names></name><name><surname>van Hul</surname><given-names>W</given-names></name><name><surname>van Gaal</surname><given-names>L</given-names></name></person-group><article-title>The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men</article-title><source>Endocrine</source><year>2007</year><volume>31</volume><fpage>138</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">17873324</pub-id><pub-id pub-id-type="doi">10.1007/s12020-007-0022-y</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benzinou</surname><given-names>M</given-names></name><name><surname>Ch&#x000e8;vre</surname><given-names>JC</given-names></name><name><surname>Ward</surname><given-names>KJ</given-names></name><name><surname>Lecoeur</surname><given-names>C</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Lobbens</surname><given-names>S</given-names></name><name><surname>Durand</surname><given-names>E</given-names></name><name><surname>Delplanque</surname><given-names>J</given-names></name><name><surname>Horber</surname><given-names>FF</given-names></name><name><surname>Heude</surname><given-names>B</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>T</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name></person-group><article-title>Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations</article-title><source>Hum Mol Genet</source><year>2008</year><volume>17</volume><fpage>1916</fpage><lpage>1921</lpage><pub-id pub-id-type="pmid">18375449</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddn089</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pagotto</surname><given-names>U</given-names></name><name><surname>Marsicano</surname><given-names>G</given-names></name><name><surname>Cota</surname><given-names>D</given-names></name><name><surname>Lutz</surname><given-names>B</given-names></name><name><surname>Pasquali</surname><given-names>R</given-names></name></person-group><article-title>The emerging role of the endocannabinoid system in endocrine regulation and energy balance</article-title><source>Endocr Rev</source><year>2006</year><volume>27</volume><fpage>73</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">16306385</pub-id><pub-id pub-id-type="doi">10.1210/er.2005-0009</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poster</surname><given-names>DS</given-names></name><name><surname>Penta</surname><given-names>JS</given-names></name><name><surname>Bruno</surname><given-names>S</given-names></name><name><surname>Macdonald</surname><given-names>JS</given-names></name></person-group><article-title>Delta 9-tetrahydrocannabinol in clinical oncology</article-title><source>JAMA</source><year>1981</year><volume>245</volume><fpage>2047</fpage><lpage>2051</lpage><pub-id pub-id-type="pmid">6262541</pub-id><pub-id pub-id-type="doi">10.1001/jama.245.20.2047</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gorter</surname><given-names>RW</given-names></name></person-group><article-title>Cancer cachexia and cannabinoids</article-title><source>Forsch Komplementarmed</source><year>1999</year><volume>6</volume><fpage>21</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">10575285</pub-id><pub-id pub-id-type="doi">10.1159/000057152</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>H</given-names></name><name><surname>Ebert</surname><given-names>MH</given-names></name><name><surname>Faden</surname><given-names>VB</given-names></name><name><surname>Goldberg</surname><given-names>SC</given-names></name><name><surname>Kaye</surname><given-names>WH</given-names></name><name><surname>Caine</surname><given-names>ED</given-names></name><name><surname>Hawks</surname><given-names>R</given-names></name><name><surname>Zinberg</surname><given-names>N</given-names></name></person-group><article-title>A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa</article-title><source>J Clin Psychopharmacol</source><year>1983</year><volume>3</volume><fpage>165</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">6308069</pub-id><pub-id pub-id-type="doi">10.1097/00004714-198306000-00004</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naruse</surname><given-names>T</given-names></name><name><surname>Amano</surname><given-names>H</given-names></name><name><surname>Koizumi</surname><given-names>Y</given-names></name></person-group><article-title>Possible involvement of dopamine D-1 and D-2 receptors in diazepam-induced hyperphagia in rats</article-title><source>Fundam Clin Pharmacol</source><year>1991</year><volume>5</volume><fpage>677</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">1838347</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naruse</surname><given-names>T</given-names></name></person-group><article-title>Effects of repeated intravenous administration of diazepam on food intake in rats</article-title><source>Fundam Clin Pharmacol</source><year>1994</year><volume>8</volume><fpage>379</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">7851844</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Bornscheuer</surname><given-names>A</given-names></name><name><surname>Depenbusch</surname><given-names>M</given-names></name><name><surname>Mierke</surname><given-names>B</given-names></name><name><surname>T&#x000f6;lle</surname><given-names>A</given-names></name><name><surname>Middeke</surname><given-names>K</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Roth</surname><given-names>H</given-names></name><name><surname>Gerber</surname><given-names>G</given-names></name><name><surname>Zamzow</surname><given-names>K</given-names></name><name><surname>Ballauff</surname><given-names>A</given-names></name><name><surname>Hamann</surname><given-names>A</given-names></name><name><surname>Mayer</surname><given-names>H</given-names></name><name><surname>Siegfried</surname><given-names>W</given-names></name><name><surname>Lehmkuhl</surname><given-names>G</given-names></name><name><surname>Poustka</surname><given-names>F</given-names></name><name><surname>Schmidt</surname><given-names>MH</given-names></name><name><surname>Hermann</surname><given-names>H</given-names></name><name><surname>Herpertz-Dahlmann</surname><given-names>BM</given-names></name><name><surname>Fichter</surname><given-names>M</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region</article-title><source>Mol Psychiatry</source><year>1998</year><volume>3</volume><fpage>539</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">9857981</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4000394</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quinton</surname><given-names>ND</given-names></name><name><surname>Meechan</surname><given-names>DW</given-names></name><name><surname>Brown</surname><given-names>K</given-names></name><name><surname>Eastwood</surname><given-names>H</given-names></name><name><surname>Blakemore</surname><given-names>AI</given-names></name></person-group><article-title>Single nucleotide polymorphisms in the leptin receptor gene: studies in anorexia nervosa</article-title><source>Psychiatr Genet</source><year>2004</year><volume>14</volume><fpage>191</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">15564891</pub-id><pub-id pub-id-type="doi">10.1097/00041444-200412000-00004</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyasaka</surname><given-names>K</given-names></name><name><surname>Hosoya</surname><given-names>H</given-names></name><name><surname>Sekime</surname><given-names>A</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Amono</surname><given-names>H</given-names></name><name><surname>Matsushita</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Higuchi</surname><given-names>S</given-names></name><name><surname>Funakoshi</surname><given-names>A</given-names></name></person-group><article-title>Association of ghrelin receptor gene polymorphism with bulimia nervosa in a Japanese population</article-title><source>J Neural Transm</source><year>2006</year><volume>113</volume><fpage>1279</fpage><lpage>1285</lpage><pub-id pub-id-type="pmid">16362631</pub-id><pub-id pub-id-type="doi">10.1007/s00702-005-0393-2</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monteleone</surname><given-names>P</given-names></name><name><surname>Tortorella</surname><given-names>A</given-names></name><name><surname>Castaldo</surname><given-names>E</given-names></name><name><surname>Di Filippo</surname><given-names>C</given-names></name><name><surname>Maj</surname><given-names>M</given-names></name></person-group><article-title>No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa</article-title><source>Neurosci Lett</source><year>2006</year><volume>398</volume><fpage>325</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">16472909</pub-id><pub-id pub-id-type="doi">10.1016/j.neulet.2006.01.023</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribas&#x000e9;s</surname><given-names>M</given-names></name><name><surname>Gratac&#x000f2;s</surname><given-names>M</given-names></name><name><surname>Armengol</surname><given-names>L</given-names></name><name><surname>de Cid</surname><given-names>R</given-names></name><name><surname>Bad&#x000ed;a</surname><given-names>A</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>L</given-names></name><name><surname>Solano</surname><given-names>R</given-names></name><name><surname>Vallejo</surname><given-names>J</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>F</given-names></name><name><surname>Estivill</surname><given-names>X</given-names></name></person-group><article-title>Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type</article-title><source>Mol Psychiatry</source><year>2003</year><volume>8</volume><fpage>745</fpage><lpage>751</lpage><pub-id pub-id-type="pmid">12888803</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4001281</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribas&#x000e9;s</surname><given-names>M</given-names></name><name><surname>Gratac&#x000f2;s</surname><given-names>M</given-names></name><name><surname>Fern&#x000e1;ndez-Aranda</surname><given-names>F</given-names></name><name><surname>Bellodi</surname><given-names>L</given-names></name><name><surname>Boni</surname><given-names>C</given-names></name><name><surname>Anderluh</surname><given-names>M</given-names></name><name><surname>Cavallini</surname><given-names>MC</given-names></name><name><surname>Cellini</surname><given-names>E</given-names></name><name><surname>Di Bella</surname><given-names>D</given-names></name><name><surname>Erzegovesi</surname><given-names>S</given-names></name><name><surname>Foulon</surname><given-names>C</given-names></name><name><surname>Gabrovsek</surname><given-names>M</given-names></name><name><surname>Gorwood</surname><given-names>P</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Holliday</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Karwautz</surname><given-names>A</given-names></name><name><surname>Kipman</surname><given-names>A</given-names></name><name><surname>Komel</surname><given-names>R</given-names></name><name><surname>Nacmias</surname><given-names>B</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Ricca</surname><given-names>V</given-names></name><name><surname>Sorbi</surname><given-names>S</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Treasure</surname><given-names>J</given-names></name><name><surname>Collier</surname><given-names>DA</given-names></name><name><surname>Estivill</surname><given-names>X</given-names></name></person-group><article-title>Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations</article-title><source>Hum Mol Genet</source><year>2004</year><volume>13</volume><fpage>1205</fpage><lpage>1212</lpage><pub-id pub-id-type="pmid">15115760</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddh137</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribas&#x000e9;s</surname><given-names>M</given-names></name><name><surname>Gratac&#x000f2;s</surname><given-names>M</given-names></name><name><surname>Fern&#x000e1;ndez-Aranda</surname><given-names>F</given-names></name><name><surname>Bellodi</surname><given-names>L</given-names></name><name><surname>Boni</surname><given-names>C</given-names></name><name><surname>Anderluh</surname><given-names>M</given-names></name><name><surname>Cristina Cavallini</surname><given-names>M</given-names></name><name><surname>Cellini</surname><given-names>E</given-names></name><name><surname>Di Bella</surname><given-names>D</given-names></name><name><surname>Erzegovesi</surname><given-names>S</given-names></name><name><surname>Foulon</surname><given-names>C</given-names></name><name><surname>Gabrovsek</surname><given-names>M</given-names></name><name><surname>Gorwood</surname><given-names>P</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Holliday</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Karwautz</surname><given-names>A</given-names></name><name><surname>Kipman</surname><given-names>A</given-names></name><name><surname>Komel</surname><given-names>R</given-names></name><name><surname>Nacmias</surname><given-names>B</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Ricca</surname><given-names>V</given-names></name><name><surname>Sorbi</surname><given-names>S</given-names></name><name><surname>Tomori</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Treasure</surname><given-names>J</given-names></name><name><surname>Collier</surname><given-names>DA</given-names></name><name><surname>Estivill</surname><given-names>X</given-names></name></person-group><article-title>Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations</article-title><source>Eur J Hum Genet</source><year>2005</year><volume>13</volume><fpage>428</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">15657604</pub-id><pub-id pub-id-type="doi">10.1038/sj.ejhg.5201351</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedel</surname><given-names>S</given-names></name><name><surname>Horro</surname><given-names>FF</given-names></name><name><surname>Wermter</surname><given-names>AK</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Dempfle</surname><given-names>A</given-names></name><name><surname>Reichwald</surname><given-names>K</given-names></name><name><surname>Smidt</surname><given-names>J</given-names></name><name><surname>Br&#x000f6;nner</surname><given-names>G</given-names></name><name><surname>Konrad</surname><given-names>K</given-names></name><name><surname>Herpertz-Dahlmann</surname><given-names>B</given-names></name><name><surname>Warnke</surname><given-names>A</given-names></name><name><surname>Hemminger</surname><given-names>U</given-names></name><name><surname>Linder</surname><given-names>M</given-names></name><name><surname>Kiefl</surname><given-names>H</given-names></name><name><surname>Goldschmidt</surname><given-names>HP</given-names></name><name><surname>Siegfried</surname><given-names>W</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name></person-group><article-title>Mutation screen of the brain derived neurotrophic factor gene (BDNF): identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder</article-title><source>Am J Med Genet B Neuropsychiatr Genet</source><year>2005</year><volume>132B</volume><fpage>96</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">15457498</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.b.30090</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ando</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>N</given-names></name><name><surname>Karibe</surname><given-names>M</given-names></name><name><surname>Oba</surname><given-names>M</given-names></name><name><surname>Tatsuta</surname><given-names>N</given-names></name><name><surname>Hara</surname><given-names>S</given-names></name><name><surname>Takii</surname><given-names>M</given-names></name><name><surname>Naruo</surname><given-names>T</given-names></name><name><surname>Takei</surname><given-names>M</given-names></name><name><surname>Kurokawa</surname><given-names>N</given-names></name><name><surname>Nozoe</surname><given-names>S</given-names></name><name><surname>Kubo</surname><given-names>C</given-names></name><name><surname>Komaki</surname><given-names>G</given-names></name></person-group><article-title>Analysis of tumor necrosis factor-alpha gene promoter polymorphisms in anorexia nervosa</article-title><source>Psychiatr Genet</source><year>2001</year><volume>11</volume><fpage>161</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">11702059</pub-id><pub-id pub-id-type="doi">10.1097/00041444-200109000-00009</pub-id></citation></ref></ref-list></back></article> 